Biotechnology Industry Market Index
The Biotechnology Industry in the Health Care Sector includes companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering (including companies specializing in protein-based therapeutics to treat human diseases).
The Biotechnology industry index is a market composite index that includes 8 stocks from public trading companies and ADRs with the largest market capitalizations in the Biotechnology industry.
The list of stocks in the Biotechnology industry includes Gilead Sciences Inc, Moderna Inc., AbbVie Inc, Biogen Inc, Amgen Inc, Vertex Pharmaceuticals Inc, Incyte Corp and Regeneron Pharmaceuticals Inc.
10/4/2022 Health Care Sector Biotechnology Industry
$253,401
Change: +2.19%
Open: $250,257
High: $254,673
Low: $248,049
| Gilead Sciences Inc (GILD) |
+4.80%
|
| Moderna Inc. (MRNA) |
+3.87%
|
| AbbVie Inc (ABBV) |
+2.65%
|
| Biotechnology Industry |
+2.19%
|
| Biogen Inc (BIIB) |
+1.19%
|
| Amgen Inc (AMGN) |
+1.12%
|
| Vertex Pharmaceuticals Inc (VRTX) |
+1.08%
|
| Incyte Corp (INCY) |
+1.06%
|
| Regeneron Pharmaceuticals Inc (REGN) |
+0.60%
|
Index Value: $253,401 +2.19%
Volume: 9.74B Average Volume (3 month): 7.96B
Market Capitalization: $258.06T
EBITDA: $28.05T
PEG Ratio (5 year Expected): 0.77
Dividend Yield: 2.23%
Dividend Rate: $5,834
Dividend Yield (Forward): 2.37%
Dividend Rate (Forward): $6,210
Shares Outstanding: 1.84T
Book Value: $34,845
Short Ratio: 1.91
Price Target (1 year): $276,846
Volume: 9.74B Average Volume (3 month): 7.96B
Market Capitalization: $258.06T
EBITDA: $28.05T
PEG Ratio (5 year Expected): 0.77
Dividend Yield: 2.23%
Dividend Rate: $5,834
Dividend Yield (Forward): 2.37%
Dividend Rate (Forward): $6,210
Shares Outstanding: 1.84T
Book Value: $34,845
Short Ratio: 1.91
Price Target (1 year): $276,846
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| GILD | Gilead Sciences Inc | 65.31 | +4.80% | 10.39M | 1.52 | 11.46% |
| MRNA | Moderna Inc. | 125.67 | +3.87% | 3.45M | 0.72 | 6.88% |
| ABBV | AbbVie Inc | 141.99 | +2.65% | 6.24M | 1.13 | 35.16% |
| Biotechnology Industry | 253,400.80 | +2.19% | 9.74B | 1.22 | 12.65% | |
| BIIB | Biogen Inc | 267.45 | +1.19% | 2.13M | 1.67 | 5.49% |
| AMGN | Amgen Inc | 233.02 | +1.12% | 2.16M | 0.83 | 17.46% |
| VRTX | Vertex Pharmaceuticals Inc | 300.64 | +1.08% | 1.54M | 1.11 | 10.80% |
| INCY | Incyte Corp | 69.56 | +1.06% | 1.15M | 0.82 | 2.17% |
| REGN | Regeneron Pharmaceuticals Inc | 739.54 | +0.60% | 874,940 | 1.26 | 10.58% |
| Symbol | Security | Market Cap | Div Yield | PEG Ratio |
| GILD | Gilead Sciences Inc | 81.858B | 4.62% | -7.62 |
| MRNA | Moderna Inc. | 49.162B | -0.12 | |
| ABBV | AbbVie Inc | 251.035B | 4.00% | -17.49 |
| Biotechnology Industry | $258.06T | 2.23% | 0.77 | |
| BIIB | Biogen Inc | 39.207B | -2.71 | |
| AMGN | Amgen Inc | 124.65B | 3.21% | 1.62 |
| VRTX | Vertex Pharmaceuticals Inc | 77.102B | 2.59 | |
| INCY | Incyte Corp | 15.472B | 2.18 | |
| REGN | Regeneron Pharmaceuticals Inc | 75.543B | -1.07 | |
Back to Market Summary